Current Report Filing (8-k)
March 10 2023 - 10:26AM
Edgar (US Regulatory)
0001117480
false
0001117480
2023-03-10
2023-03-10
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): March 10, 2023
Chimerix, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-35867 |
|
33-0903395 |
(State or other jurisdiction of
incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
2505 Meridian Parkway, Suite 100
Durham, NC 27713
(Address of principal executive offices, including zip code)
(919) 806-1074
(Registrant’s
telephone number, including area code)
N/A
(Former name
or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of
the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Common Stock, par value $0.001 per share |
CMRX |
The Nasdaq Global Market |
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of
the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 7.01 | Regulation FD Disclosure. |
Chimerix, Inc. (“Chimerix”) is aware
of media reports indicating a possible liquidity concern at Silicon Valley Bank (“SVB”). Chimerix considers its exposure to
any liquidity concern at SVB as immaterial, given that cash held at SVB is at or near the FDIC-insured limit of $250,000. Multiple institutions
serve as custodians for third-party investments held in Chimerix’s name which are not directly exposed to any consequences of a
liquidity concern at SVB.
The information in this Item 7.01 is being furnished and shall not
be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject
to the liabilities of that Section. The information in this Item 7.01 shall not be incorporated by reference into any registration statement
or other document pursuant to the Securities Act of 1933, as amended.
Forward-Looking Statements
The Company cautions you that statements included
in this report that are not a description of historical facts are forward-looking statements. These forward-looking statements include
statements regarding any liquidity concern. The inclusion of forward-looking statements should not be regarded as a representation by
the Company that any of these results will be achieved. Actual results may differ from those set forth in this report due to the risks
and uncertainties associated with liquidity concerns, as well as risks and uncertainties inherent in the Company’s business, including
those described in the Company’s other filings with the Securities Exchange Commission. You are cautioned not to place undue reliance
on these forward-looking statements, which speak only as of the date hereof, and the Company undertakes no obligation to revise or update
this report to reflect events or circumstances after the date hereof. All forward-looking statements are qualified in their entirety by
this cautionary statement. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform
Act of 1995.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: March 10, 2023 |
Chimerix, Inc. |
|
|
|
|
By: |
/s/ Michael T. Andriole |
|
Name: |
Michael T. Andriole |
|
Title: |
Chief Business and Financial Officer |
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Jul 2023 to Jul 2024